Page last updated: 2024-10-25

deferoxamine and Rheumatic Diseases

deferoxamine has been researched along with Rheumatic Diseases in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pall, H1
Blake, DR1
Winyard, P1
Lunec, J1
Williams, A1
Good, PA1
Kritzinger, EE1
Cornish, A1
Hider, RC1

Other Studies

1 other study available for deferoxamine and Rheumatic Diseases

ArticleYear
Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?
    The British journal of ophthalmology, 1989, Volume: 73, Issue:1

    Topics: Aged; Copper; Deferoxamine; Electrooculography; Electroretinography; Evoked Potentials, Visual; Eye

1989